Gut microbial‐derived 3,4‐dihydroxyphenylacetic acid ameliorates reproductive phenotype of polycystic ovary syndrome
iMeta · 2025-10 · 4 (5)
DOI: 10.1002/imt2.70065 ↗Kurz gefasst
Fachartikel in der Zeitschrift iMeta, online erschienen am 15.07.2025. Verfasst von Pan Li und 22 weiteren Autor:innen. Beteiligte Einrichtung: Ningbo Key Laboratory of Human Microbiome and Precision Medicine, Central Laboratory of the Medical Research Center The First Affiliated Hospital of …. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Polycystic ovary syndrome (PCOS) is a prevalent endocrine and reproductive disorder affecting women of reproductive age. While the gut microbiota has been implicated in PCOS pathophysiology, the role of microbial‐derived metabolites as mediators of host–microbe interactions remains poorly defined. Here, we integrated untargeted gut metabolomics with metagenomic profiling in patients with PCOS and identified a marked depletion of 3,4‐dihydroxyphenylacetic acid (DHPAA), a flavonoid‐derived microbial catabolite. Oral administration of DHPAA ameliorated PCOS‐like phenotypes in two mouse models by suppressing bone morphogenetic protein signaling and reducing anti‐Müllerian hormone (AMH) levels. We found that DHPAA production depends on gut microbial degradation of dietary flavonoids. We further identified a bacterial species, Streptococcus thermophilus , consistently depleted in PCOS across two human cohorts and a mouse model, restored DHPAA levels and improved reproductive outcomes in mice. Conversely, a β‐galactosidase‐deficient mutant of S. thermophilus failed to confer these benefits, highlighting β‐galactosidase as a critical enzyme in DHPAA biosynthesis. Our findings establish DHPAA as a key microbial metabolite linking diet, microbiota, and reproductive health, and propose its potential as a novel therapeutic candidate for PCOS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ningbo Key Laboratory of Human Microbiome and Precision Medicine, Central Laboratory of the Medical Research Center The First Affiliated Hospital of Ningbo University Ningbo China.
- Department of Obstetrics and Gynecology The First Affiliated Hospital of Ningbo University Ningbo China.
- UNSW Microbiome Research Centre St George and Sutherland Clinical Campuses, UNSW Sydney Australia.
- Department of Obstetrics, Affiliated Foshan Maternity & Child Healthcare Hospital Southern Medical University Foshan China.
- Institute of Ecological Science, School of Life Science South China Normal University Guangzhou China.
- The Second Clinical Medical College Southern Medical University Guangzhou China.
ORCID-Profile: Huimin Zheng, Guangchuang Yu, Xia Chen
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- China Postdoctoral Science Foundation
Zitieren
APA
Li, P., Xie, L., Zheng, H., Feng, Y., Mai, F., Tang, W., Wang, J., Lan, Z., Lv, S., Jayawardana, T., Koentgen, S., Xu, S., Wan, Z., Chen, Y., Xu, H., Shen, S., Zhang, F., Yang, Y., Hold, G., …, & Chen, X. (2025). Gut microbial‐derived 3,4‐dihydroxyphenylacetic acid ameliorates reproductive phenotype of polycystic ovary syndrome. iMeta, 4(5). https://doi.org/10.1002/imt2.70065
Vancouver
Li P, Xie L, Zheng H, Feng Y, Mai F, Tang W, et al. Gut microbial‐derived 3,4‐dihydroxyphenylacetic acid ameliorates reproductive phenotype of polycystic ovary syndrome. iMeta. 2025;4(5). doi:10.1002/imt2.70065
BibTeX
@article{Li2025,
author = {Li, Pan and Xie, Li and Zheng, Huimin and Feng, Yinglin and Mai, Feihong and Tang, Wenli and Wang, Jiajia and Lan, Zixin and Lv, Shuaijun and Jayawardana, Thisun and Koentgen, Sabrina and Xu, Shuangbin and Wan, Zhengwei and Chen, Yunjie and Xu, Haiyan and Shen, Sj and Zhang, Fan and Yang, Yuanhao and Hold, Georgina and He, Fangjie and El-Omar, Emad M and Yu, Guangchuang and Chen, Xia},
title = {Gut microbial‐derived 3,4‐dihydroxyphenylacetic acid ameliorates reproductive phenotype of polycystic ovary syndrome},
journal = {iMeta},
year = {2025},
volume = {4},
number = {5},
doi = {10.1002/imt2.70065}
}
EUVIMED